Related Experiment Video

Updated: Aug 19, 2026

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors
09:04

A Simple Bioassay for the Evaluation of Vascular Endothelial Growth Factors

Published on: March 15, 2016

Transcriptional regulation of vascular endothelial growth factor in cancer

Robyn M B Loureiro1, Patricia A D'Amore

  • 1Schepens Eye Research Institute, 20 Staniford Street, Harvard Medical School, Boston, MA 02114, USA. rloureiro@vision.eri.harvard.edu

Cytokine & Growth Factor Reviews
|March 1, 2005
PubMed

Insights

Vascular endothelial growth factor (VEGF) drives tumor vascularization. Understanding its transcriptional regulation in cancer is key to developing therapies targeting tumors and their blood supply.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Vascular endothelial growth factor (VEGF) is crucial for tissue vascularization, including tumor growth.
  • VEGF is a key target for anti-angiogenesis strategies in cancer therapy.
  • While developmental regulation of VEGF is unclear, its pathological role in disease is better understood.

Purpose of the Study:

  • To review the transcriptional regulation of VEGF expression specifically within cancer cells.
  • To elucidate the molecular mechanisms controlling VEGF production in tumors.
  • To provide a foundation for novel therapeutic strategies targeting tumor angiogenesis.

Main Methods:

  • Literature review focusing on transcriptional regulation of VEGF.
  • Analysis of molecular pathways involved in VEGF gene expression in cancer.
  • Synthesis of current knowledge on VEGF regulation in tumorigenesis.

Main Results:

  • Transcriptional regulation is a primary mechanism controlling VEGF levels in tumors.
  • Specific transcription factors and signaling pathways are identified as key regulators.
  • Dysregulation of these pathways contributes to aberrant VEGF expression in cancer.

Conclusions:

  • Understanding VEGF transcriptional regulation in cancer is essential for effective anti-angiogenesis therapy.
  • Targeting these regulatory mechanisms offers a promising approach for cancer treatment.
  • Further research into VEGF regulation can lead to novel therapeutic interventions.

More Related Videos

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling07:49

Molecular Analysis of Endothelial-mesenchymal Transition Induced by Transforming Growth Factor-β Signaling

Published on: August 3, 2018

Isolation and Culture Expansion of Tumor-specific Endothelial Cells10:15

Isolation and Culture Expansion of Tumor-specific Endothelial Cells

Published on: October 14, 2015

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...